APA (7th ed.) Citation

R, M., MA, N., BV, S., UC, L., P, M., H, C., & D, I. (2026). Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteria. Lupus, 35(9), 918. https://doi.org/10.1177/09612033261449991

Chicago Style (17th ed.) Citation

R, Meidan, Nadal MA, Sosa BV, Lareo UC, Mittal P, Cohen H, and Isenberg D. "Morbidity and Mortality in Primary Versus Secondary Antiphospholipid Syndrome: A Single-center Study Using the 2023 ACR/EULAR Criteria." Lupus 35, no. 9 (2026): 918. https://doi.org/10.1177/09612033261449991.

MLA (9th ed.) Citation

R, Meidan, et al. "Morbidity and Mortality in Primary Versus Secondary Antiphospholipid Syndrome: A Single-center Study Using the 2023 ACR/EULAR Criteria." Lupus, vol. 35, no. 9, 2026, p. 918, https://doi.org/10.1177/09612033261449991.